Login
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
30 January 2025 at 18:12
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
Normal view
Before yesterdayMain stream
